BeiGene Expands Presence in Latin America With Opening of Brazil Office
PD-1 inhibitor tislelizumab under review by Brazil’s National Health Surveillance Agency to treat non-small cell lung cancer and esophageal cancer Future regional expansion planned in... | April 13, 2023